missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. 18276650

Novus Biologicals™ p19ARF/CDKN2A Antibody Blocking Peptide

Product Code. 18276650 Shop All Bio Techne Products
Click to view available options
Quantity:
0.05 mg
Unit Size:
0.05mg
This item is not returnable. View return policy

Product Code. 18276650

Brand: Novus Biologicals™ NB200106PEP

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

A peptide to CDKN2A.
TRUSTED_SUSTAINABILITY

Specifications

Gene ID (Entrez) 12578
Species Human
Content And Storage Store at -80 C. Avoid freeze-thaw cycles.
Formulation Peptide dissolved in dH2O. Contains no BSA.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NB 200-106. For Further Blocking Peptide Related Protocol, Click Here .
Gene Alias alternative reading frame, ARF, ARF-INK4a, CDK4I, CDKN2A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2 A, cyclin-dependent kinase inhibitor 2 A (p16, inhibits CDK4), cyclin-dependent kinase inhibitor 2 A, isoform 3, cyclin-dependent kinase inhibitor 2 A, isoforms 1/2, cyclin-dependent kinase inhibitor protein, INK4, INK4a, Ink4a/Arf, INK4a-ARF, mitochondrial smARF', MTS1, p14, p14ARF, P16, p16(INK4a), p16-INK4, p16INK4a, p16-INK4a, P19, p19, p19ARF, Pctr1
Gene Symbol Cdkn2a
Product Type p19ARF
Quantity 0.05 mg
Regulatory Status RUO - research use only
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.